《HIV-1亚型E重组起源假说的验证》

  • 来源专题:艾滋病防治
  • 编译者: 李越
  • 发布时间:2005-04-20
  • The human immunodeficiency virus type 1 (HIV-1) epidemic in Southeast Asia has been largely due to the emergence of clade E (HIV-1E). It has been suggested that HIV-1E is derived from a recombinant lineage of subtype A (HIV-1A) and subtype E, with multiple breakpoints along the E genome. We obtained complete genome sequences of clade E viruses from Thailand (93TH057 and 93TH065) and from the Central African Republic (90CF11697 and 90CF4071), increasing the total number of HIV-1E complete genome sequences available to seven. Phylogenetic analysis of complete genomes showed that subtypes A and E are themselves monophyletic, although together they also form a larger monophyletic group. The apparent phylogenetic incongruence at different regions of the genome that was previously taken as evidence of recombination is shown to be not statistically significant. Furthermore, simulations indicate that bootscanning and pairwise distance results, previously used as evidence for recombination, can be misleading, particularly when there are differences in substitution or evolutionary rates across the genomes of different subtypes. Taken jointly, our analyses suggest that there is inadequate support for the hypothesis that subtype E variants are derived from a recombinant lineage. In contrast, many other HIV strains claimed to have a recombinant origin, including viruses for which only a single parental strain was employed for analysis, do indeed satisfy the statistical criteria we propose. Thus, while intersubtype recombinant HIV strains are indeed circulating, the criteria for assigning a recombinant origin to viral structures should include statistical testing of alternative hypotheses to avoid inappropriate assignments that would obscure the true evolutionary properties of these viruses.
  • 原文来源:http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=110950
相关报告
  • 《非洲HIV-1亚型的困惑》

    • 来源专题:艾滋病防治
    • 编译者:李越
    • 发布时间:2005-03-03
    • The genetic variation of microorganisms and their evolution in time have important implications for the control of infectious diseases. Genetic variation may be reflected in differences in biological characteristics that may determine transmissibility, pathogenesis, and immunogenicity. Genetic variability of microorganisms needs to be taken into account when developing or adapting diagnostic tests and vaccines, and when makingprojections of the burden of morbidity and mortality.Identification of strains or subtypes has also proved to be an invaluable tool in studying the spread of infectious pathogens.
  • 《遗传亚型、人体免疫和HIV-1疫苗的发展》

    • 来源专题:艾滋病防治
    • 编译者:李越
    • 发布时间:2005-04-17
    • Successful vaccination programs, particularly against influenza virus infection, have provided us with an awareness of the need to immunize against the predominant circulating viral strains or genetic subtypes. The lessons and language derived from experience with influenza (and a few other) viruses have often been directly translated to human immunodeficiency virus type 1 (HIV-1) vaccine development. But how appropriate is this? Should an HIV-1 vaccine antigen always be based on the dominant genetic subtype that circulates in the geographical area where a vaccine candidate is to be tested? The answers lie, at least in part, in a consideration of the humoral response to HIV-1 and, in particular, in the relationships between the HIV-1 genetic subtypes and antigenic and neutralization serotypes. Here, we will review what is known about these relationships and seek to clarify confusion that has been created by the use of serological assays that generate misleading, or sometimes artifactual, results. Broadly similar issues are raised when considering the relationship between cellular immune responses and the HIV-1 genetic subtypes, but we will not discuss these here. Instead, we refer the reader to recent articles written by leading cellular immunologists . Significantly, a recent study on the cross-clade activity of cytotoxic T-lymphocyte responses in HIV-1-infected Ugandans argued that the use of nonendemic vaccine strains may be initially justified from the perspective of inducing cellular immunity to HIV-1.